Shantou University
Also known as: Cancer Hospital of Shantou University | Cancer Hospital, Shantou University Medical College | Department of Nephrology, People's Hospital Guangdong Provincial | Department of nephrology, People's Hospital of Guangdong Province | First Affiliated Hospital of Shantou University Medical College | First Affiliated Hospital of Shantou University Medical Collegeity | Guangdong Cardiovascular Insititution, Guangdong General Hospital, Guangdong Academy of Medical Science | Guangdong Cardiovascular Institute,Guangdong General Hospital | Guangdong General Hospita | Guangdong General Hospital | Guangdong General Hospital (GGH)& Guangdong Academy of Medical Sciences | Guangdong General Hospital, Guangdong, 510030, China | Guangdong General Hospital & Guangdong Academy of Medical Sciences | Guangdong General Hospital, Guangdong Academy of Medical Sciences | Guangdong General Hospital&Guangdong Academy of Medical Sciences | Guangdong Province People's Hospital | Guangdong Provincial People's Hospital | Jiyan Chen | Longgang District Central Hospital of Shenzhen | Nephrology Dept,Guangdong General Hospital | Nephrology Dept.,Guangdong General Hospital | No. 106 Zhongshan er Road, Guangzhou, Guangdong | People's Hospital Guangdong Provincial | People's Hospital of Guangdong Province | Shantou Central Hospital | Shantou University Medical College | The Second Affiliated Hospital of Shantou University Medical College
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2006Last known activity
Jan 1, 2026
Timeline
1980s
- Jan 1, 1981
Shantou University— Founded
Drugs by trial phase (243 distinct, 246 trials)
Phase 4 (63 own, 0 via acquisition)
Phase 3 (65 own, 0 via acquisition)
Phase 2 (57 own, 0 via acquisition)
Phase 1 (21 own, 0 via acquisition)
Other trials (37 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Amyloidosis
- Anemia
- Anemia, Aplastic
- Atrial Fibrillation
- Brain Neoplasms
- Breast Neoplasms
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cardiovascular Diseases
- Cerebral Small Vessel Diseases
- Cognitive Dysfunction
- Colorectal Neoplasms
- Communicable Diseases
- Compulsive Personality Disorder
- Cytomegalovirus Infections
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dry Eye Syndromes
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Glaucoma
- Glomerulonephritis
- Glomerulonephritis, IGA
- Glomerulonephritis, Membranous
- Gout
- Graft vs Host Disease
- Head and Neck Neoplasms
- Hematologic Diseases
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hypercalcemia
- Hyperglycemia
- Hyperhomocysteinemia
- Hyperparathyroidism
- Hypertension
- Hypertension, Pulmonary
- Immunoglobulin Light-chain Amyloidosis
- Infarction
- Infections
- Invasive Fungal Infections
- Keratoconjunctivitis Sicca
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lupus Nephritis
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Musculoskeletal Pain
- Mycoses
- Myocardial Infarction
- Myocardial Reperfusion Injury
- Nasopharyngeal Carcinoma
- Nasopharyngeal Diseases
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neoplasm, Residual
- Neoplasms
- Neoplasms, Second Primary
- Nephritis
- Nephrosis
- Nephrotic Syndrome
- Neuroendocrine Tumors
- Obsessive-Compulsive Disorder
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Philadelphia Chromosome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prehypertension
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Syndrome
- Thoracic Neoplasms
- Thrombocytopenia
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07199023CollaboratorN/AJan 1, 2026
- NCT07296809OfficialPhase 2Dec 20, 2025
- NCT06968806CollaboratorPhase 3Oct 27, 2025
- NCT07156656CollaboratorPhase 4Sep 1, 2025
- NCT07136558OfficialPhase 1Aug 31, 2025
- NCT07136792Sponsor investigatorN/AAug 31, 2025
- NCT07136792Lead sponsorN/AAug 31, 2025
- NCT07136792OfficialN/AAug 31, 2025
- NCT07120698CollaboratorPhase 2Aug 26, 2025
- NCT07038460Lead sponsorPhase 2Jul 31, 2025
- NCT07038460Sponsor investigatorPhase 2Jul 31, 2025
- NCT07005661CollaboratorPhase 2/Phase 3Jun 30, 2025
- NCT06946927OfficialPhase 1Jun 6, 2025
- NCT07047547OfficialN/AJun 1, 2025
- NCT07047547Sponsor investigatorN/AJun 1, 2025
Details
- Founded
- Shantou, CN Jan 1, 1981
- Last known activity
- Jan 1, 2026